Assignee
ONCOC4 INC
US7 patents
Top patents by PatentIndex Score
US11261233B2Mar 1, 2022
CD80 and CD86 binding protein compositions and uses thereof
ONCOC4 INC6 citations83
US12227557B2Feb 18, 2025
CD80 and CD86 binding protein compositions and uses thereof
ONCOC4 INC2 citations72
US12473362B2Nov 18, 2025
Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof
ONCOC4 INC0 citations61
US11629188B2Apr 18, 2023
Chimeric and humanized anti-human CTLA4 monoclonal antibodies and uses thereof
ONCOC4 INC0 citations61
US12441780B2Oct 14, 2025
CD80 and CD86 binding protein compositions and uses thereof
ONCOC4 INC0 citations60
US12129299B2Oct 29, 2024
Mutant anti-CTLA-4 antibodies with improved immunotherapeutic effect but attenuated adverse effects
ONCOC4 INC0 citations60
US12286485B2Apr 29, 2025
Anti-CD24 compositions and uses thereof
ONCOC4 INC0 citations50